This notice is given by Mesoblast Limited (ABN 68 109 431 870) (Mesoblast) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).

Mesoblast has issued 35,956,285 (out of the 60,109,290) fully paid ordinary shares (Shares) at an issue price of US$1.83 (A$2.30) per Share to sophisticated and professional investors under the private placement led by a strategic US investor group announced on 2 March 2021.

Mesoblast advises that: 1 the Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act; 2 this notice is being given under section 708A(5)(e) of the Corporations Act; 3 as at the date of this notice, Mesoblast has complied with: (a) the provisions of Chapter 2M of the Corporations Act, as they apply to Mesoblast and (b) section 674 of the Corporations Act and 4 as at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708A(8) of the Corporations Act.

Contact:

Schond Greenway

Tel: + 1 212 880 2060

Email: schond.greenway@mesoblast.com

(C) 2021 Electronic News Publishing, source ENP Newswire